Epsilon M&A Deal Report - Etablissements Pascual
Transaction Multiples for the Valuation of Private Companies
Anjac / Etablissements Pascual
No EMAT :
102463
Announced Date :
26/04/2018
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Anjac
Target :
Etablissements Pascual
Country :
Seine-Et-Marne
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Personal Products
Business Description :
Founded in 2010, Etablissements Pascual (Pascual Cosmétiques) offers the international cosmetics industry the «made in France» competence: creativity, innovation, formulation, manufacturing, filling...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
|
|
| Current |
|
|
|
|
|
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Personal Products » = 129
| Date | Acquirer | Target | Country | Multiples | See details |
| 30/07/2020 | Private Group led by Stanley Capital | Noden Pharma Designated Activity Company | Ireland | * | 102415 |
| 21/09/2020 | Roche | Inflazome | Ireland | * | 102408 |
Source: Epsilon Research / EMAT
